STAAR Surgical Company (NASDAQ:STAA) has made a 164.56% comeback from a 12-month low price of $13.6. It was seen -3.46% lower, changing the price to $35.98, when the closing bell rang on 3/14/2019. At a recent session, the prices were hovering between $35.97 and $37.3. This company shares are 48% off its target price of $53.25 and the current market capitalization stands at $1.62B. The recent change has given its price a 2.88% lead over SMA 50 and -33.37% deficit over its 52-week high. The stock witnessed -1.29% declines, 2.19% gains and -28.82% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found STAA’s volatility during a week at 2.8% and during a month it has been found around 4.76%.STAAR Surgical Company (STAA) Top Holders
Institutional investors currently hold around $1.49 billion or 90.9% in STAA stock. Look at its top three institutional owners: Broadwood Capital Inc owns $400.3 million in STAAR Surgical Company, which represents roughly 24.71% of the company’s market cap and approximately 26.96% of the institutional ownership. Similar statistics are true for the second largest owner, Palo Alto Investors Lp, which owns 4,147,988 shares of the stock are valued at $154.6 million. The third largest holder is Vanguard Group Inc, which currently holds $134.17 million worth of this stock and that ownership represents nearly 8.28% of its market capitalization.STAAR Surgical Company 13F Filings
At the end of December reporting period, 101 institutional holders increased their position in STAAR Surgical Company (NASDAQ:STAA) by some 5,260,252 shares, 99 decreased positions by 3,386,601 and 16 held positions by 31,200,885. That puts total institutional holdings at 39,847,738 shares, according to SEC filings. The stock grabbed 24 new institutional investments totaling 1,637,285 shares while 37 institutional investors sold out their entire positions totaling 968,182 shares.STAAR Surgical Company (STAA) Analyst Guide
Several analysts have released their opinion on STAAR Surgical Company (NASDAQ:STAA), with 5 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation [T1].